Project Grant R21GM164987
- Federal Grant Award Summary Stony Brook University received a $432,569 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded on March 5, 2026, with a completion date of February 28, 2031. The research initiative, titled "Deciphering the Regulatory Mechanisms of Extracellular Particle-Mediated Signaling," focuses on elucidating how cells regulate the heterogeneous profiles of...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded $436,361.00 under the Biomedical Research and Research Training program (CFDA 93.859) to support a five-year project (August 1, 2025 – July 31, 2030) focused on advancing protein structure determination methodologies. The Research Foundation for the State University of New York, serving as the fiscal agent for research conducted in Buffalo, will develop innovative computational algorithms and...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded $343,007 in Project Grant funding on June 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to support a research initiative titled "Characterizing Glycosylation Regulatory Networks Using Single-Cell Multiomics and Mathematical Modeling." The Research Foundation for the State University of New York, serving as the fiscal agent, administers the award...
- Federal Grant Award Summary Stony Brook University received a $436,001 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective August 1, 2025 through July 31, 2027. The award supports development of an efficient and accessible spatial transcriptomics platform designed to deliver gene expression data at single-cell resolution within tissue spatial context. The project addresses current...
- Federal Project Grant Award Summary The Research Foundation For The State University Of New York, operating as Upstate Medical Center, received a $448,250 Project Grant from the National Institute of General Medical Sciences under the Biomedical Research and Research Training program (CFDA 93.859), awarded August 15, 2025, with completion targeted for June 30, 2030. This award funds the development of sulfonium lipid nanoparticles (SLNPs) as a novel platform for messenger ribonucleic acid (mRNA)...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded $125,000 to Columbia University's Health Sciences Division under the Biomedical Research and Research Training program (CFDA 93.859) on May 13, 2026, with completion targeted for April 30, 2028. This Project Grant supports research directed by a postdoctoral researcher in Dr. Anum Glasgow's laboratory to develop an integrated computational and experimental platform for decoding, modulating, and...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded The Research Foundation for the State University of New York a Project Grant of $428,848 effective August 15, 2025, through June 30, 2030, under the Biomedical Research and Research Training program (CFDA 93.859). The award supports a two-year interdisciplinary training program at the University at Buffalo's Jacobs School of Medicine and Biomedical Sciences and School of Dental Medicine designed to...
- Federal Project Grant Award Summary Cornell University received a $375,154 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded June 1, 2026, with completion targeted for February 28, 2031. The award supports fundamental research to uncover the structure and function of understudied membrane proteins implicated in human diseases. The research employs Caenorhabditis elegans as a model...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded $551,154 to The Research Foundation For The State University Of New York (SUNY at Binghamton) under the Biomedical Research and Research Training program (CFDA 93.859) for a five-year project period beginning April 1, 2026 and concluding March 31, 2031. The award supports the development of advanced chemical tools and linker technologies for next-generation antibody-drug conjugates (ADCs)....
- Federal Project Grant Award Summary Southern Utah University received a $155,695 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 5, 2025, through August 31, 2029. The award funds undergraduate biomedical research focused on engineering extracellular vesicles (EVs) derived from bovine milk as a targeted drug delivery system for glioblastoma therapy. The research project...
The National Institute of General Medical Sciences (NIGMS) awarded $455,610 to The Research Foundation for The State University of New York (RF SUNY) at Binghamton under the Biomedical Research and Research Training program (CFDA 93.859) for a two-year project period running from July 1, 2026 through June 30, 2028. This Project Grant funds the development of SHEPRD (Sonic Hedgehog for EV-POI Registry and Dispersal), a novel technology platform designed to direct the packaging of specific proteins and peptides of interest into mammalian extracellular vesicles (EVs) with high efficiency and minimal immunogenic risk. The primary deliverables under this award include establishing the technical feasibility of SHEPRD as a broadly applicable protein loading system that demonstrates sequence and structure independence across multiple cell lines. Key objectives include validating that EV loading is triggered by a synthetic sterol inducer (2-alpha carboxy cholestanol) in a dose-dependent manner, confirming selectivity against endogenous sterols and structural isomers, and demonstrating rapid and measurable induction kinetics. The research builds on the team's 13 years of experience in Hedgehog protein biochemistry and aims to minimize foreign tag sequences to a single glycine residue, thereby reducing immunogenicity while preserving protein function for future translational biomedical applications.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $455.6k | 5/28/26 |